HORMONE-REFRACTORY PROSTATE CANCER
Clinical trials for HORMONE-REFRACTORY PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new HORMONE-REFRACTORY PROSTATE CANCER trials appear
Sign up with your email to follow new studies for HORMONE-REFRACTORY PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Genetic test could match men to more effective cancer drug
Disease control OngoingThis study is testing whether a genetic test can identify men with advanced prostate cancer who are most likely to benefit from a specific chemotherapy drug called carboplatin. It involves two parts: first, screening patients for specific inherited genetic changes, and second, tr…
Matched conditions: HORMONE-REFRACTORY PROSTATE CANCER
Phase: PHASE2 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Brain scans reveal hidden side effects of prostate cancer drugs
Knowledge-focused OngoingThis study investigates whether two common prostate cancer drugs (abiraterone acetate and enzalutamide) affect thinking, memory, and brain function. Researchers are following 100 men with advanced prostate cancer, using brain scans and cognitive tests to measure changes over time…
Matched conditions: HORMONE-REFRACTORY PROSTATE CANCER
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC